Abstract: Disclosed herein are methods, pharmaceutical compositions, and vaccines for modulating an immune response. Also disclosed herein are methods, pharmaceutical compositions, and vaccines for inducing an immune response.

Abstract: A frozen dough comprising flour, a high yeast level comprising one or more yeast with activity covering temperature range of 33-140° F., emulsifiers, dough conditioners, stabilizers, sugar, lipid source and optionally supplemental gluten such that the frozen dough does not require a conventional proofing (proofer) step prior to freezing or prior to baking. When the frozen dough is thawed in a retarder at 33-42° F. for at least 12 hours, or at an elevated temperature of between 43-85° F. for at least 1 hour, and then baked, the baked products have good appearance, taste and texture, and a specific volume of at least 4 cc/gram.

Abstract: A frozen dough comprising flour, a high yeast level comprising one or more yeast with activity covering temperature range of 33-140° F., emulsifiers, dough conditioners, stabilizers, sugar, lipid source and optionally supplemental gluten such that the frozen dough does not require a conventional proofing (proofer) step prior to freezing or prior to baking. When the frozen dough is thawed in a retarder at 33-42° F. for at least 12 hours, or at an elevated temperature of between 43-85° F. for at least 1 hour, and then baked, the baked products have good appearance, taste and texture, and a specific volume of at least 4 cc/gram.

Abstract: A frozen dough comprising flour, a high yeast level comprising one or more yeast with activity covering temperature range of 33-140° F., emulsifiers, dough conditioners, stabilizers, sugar, lipid source and optionally supplemental gluten such that the frozen dough does not require a conventional proofing (proofer) step prior to freezing or prior to baking. When the frozen dough is thawed in a retarder at 33-42° F. for at least 12 hours, or at an elevated temperature of between 43-85° F. for at least 1 hour, and then baked, the baked products have good appearance, taste and texture, and a specific volume of at least 4 cc/gram.

Abstract: A non-sheeted, non-laminated freezer to oven dough is provided comprising flour, water, a chemical leavening system with soda present in an amount of about 0.4% to about 1.5% by weight (as compared to the amount of flour) and an acid ingredient (SALP), and from about 3% to about 6% by weight of yeast, where the frozen dough does not require proofing. Preferably, the dough is shaped into the form of a square or a round shape, or molded into dinner rolls, rolled breadsticks or breads and the like. The dough may contain additional ingredients. The dough may be mixed with fruits/nuts, or with savory ingredients, or topped with one or more toppings, or smeared with a layer of a paste and rolled and cut into a swirl. Also provided is a method of making frozen dough and methods of making baked products which do not require proofing the dough.

Abstract: A non-laminated, non-pre-proofed frozen dough has been prepared that can go directly from the freezer to the oven to produce a high quality baked product in a short period of time. Flour, water, yeast and dough conditioner are mixed to form dough. The dough is preferably rested for about 10 or more then frozen. The frozen dough can then be thawed, proofed, and baked, preferably in a multi-phase oven. The dough preferably has a specific volume of less than 1.5 and preferably yields a baked product having a specific volume of about 4 cc/g or more.